Despite COVID, Pharma Deals Set Records

Mega-deals were few last year, but pharmaceutical deal-making hit record levels. Nearly 2,000 transactions were recorded in 202 with a value of almost $200 billion.

One in five deals involved some aspect of COVID treatment or prevention, though these accounted for less than 3% of the total deal value,” says a new report from the biosciences intelligence group Cortellis. “Consistent with the historic trend, oncology remains the most attractive therapeutic area for deal making.”

A blockbuster year for biopharma deal making says that 2020 “ended up being a solid year for the biopharmaceutical industry. Records were broken by financing transactions, and several deals and M&As fell within the highest values on record.”

The biggest M&A deal was AbbVie’s $63 billion acquisition of Allergan. Though it closed during the year, the purchase was announced well before the SAR-CoV-2 virus first appeared. A second mega-deal — AstraZeneca’s buyout of Alexion Pharmaceuticals for $39 billion – was announced in December but won’t close until late this year.

However, most of the 147 M&A transactions were smaller, collectively totaling $181.3 billion, far below the banner $256 billion in 2015 and 19% below 2019. The report says “About 82% of the M&As were “bolt-ons” or those in which an acquirer was attaching itself to needed technology. The rest were financial, expansion and mega-deals.”

Though M&A activity was slower than in the past, the1,580 financing transactions were 42% higher than 2019. According to the report, “Collectively, global public and private biopharmaceutical companies raised approximately $134 billion, which is almost double the previous record of approximately $69 billion set in 2015. It is also greater than the combined amount generated in 2018 and 2019.”

The largest share of the global financings (70%) went to US companies, with firms based in California and Massachusetts capturing $34.1 billion and $26.8 billion, respectively. New York trailed the two leaders with $6.7 billion.

Summarizing the year, the report points to the “culture of collaboration that developed between competitors” driven by the need to develop COVID treatments and vaccines.

“It will be interesting to see whether this newfound enthusiasm for cooperation can be adapted to tackle other major unmet medical needs. Continued deal-making can only strengthen this collaborative spirit within the biopharma ecosystem, benefiting shareholders and patients alike.”

Photo by JOSHUA COLEMAN on Unsplash

#WeAreGreenKey: Spotlight on Reilly Hickey
General Interest Green Key News Human Resources Professional Support Worklife

#WeAreGreenKey: Spotlight on Reilly Hickey

Green Key Unlocked: Keys to Success in Agency Recruiting
General Interest Green Key News Worklife

Green Key Unlocked: Keys to Success in Agency Recruiting

Resume Tricks for 2022
General Interest Green Key News Worklife

Resume Tricks for 2022

#WeAreGreenKey: Spotlight on Kornelia Klukowska
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Kornelia Klukowska

When to Say Goodbye to a Candidate
General Interest Green Key News Worklife

When to Say Goodbye to a Candidate

#WeAreGreenKey: Spotlight on Allison Vogt
General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Allison Vogt

Green Key Unlocked: The Growth of Professional Support
General Interest Green Key News Professional Support Worklife

Green Key Unlocked: The Growth of Professional Support

#WeAreGreenKey: Spotlight on Brittany Leader
General Interest Green Key News Healthcare Worklife

#WeAreGreenKey: Spotlight on Brittany Leader

Green Key Unlocked: FAQs of Working with a Recruiter
General Interest Green Key News Pharma Worklife

Green Key Unlocked: FAQs of Working with a Recruiter

Green Key Announces New Senior Partners
General Interest Green Key News Worklife

Green Key Announces New Senior Partners

Green Key Against Gun Violence
General Interest Green Key News

Green Key Against Gun Violence

How to Support Mental Health in the Workplace
General Interest Green Key News Worklife

How to Support Mental Health in the Workplace

#WeAreGreenKey: Spotlight on Larry Goodman
General Interest Green Key News Pharma Worklife

#WeAreGreenKey: Spotlight on Larry Goodman

#WeAreGreenKey: Spotlight on Mike Glock
Accounting + Finance Financial Services General Interest Worklife

#WeAreGreenKey: Spotlight on Mike Glock

How to Make Your Candidate an Attractive Offer
General Interest Green Key News Worklife

How to Make Your Candidate an Attractive Offer

Tips for Recent Grads
General Interest Green Key News Worklife

Tips for Recent Grads

#WeAreGreenKey: Spotlight on Patrick Friel
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Patrick Friel

Working Moms at GKR
General Interest Green Key News Healthcare Human Resources Pharma Professional Support Worklife

Working Moms at GKR

Green Key Resources Opens New Jersey Office
General Interest Green Key News Worklife

Green Key Resources Opens New Jersey Office

#WeAreGreenKey: Spotlight on Tim Durkin
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Tim Durkin

Latest Blog Posts
View All Posts
#WeAreGreenKey: Spotlight on Reilly Hickey

#WeAreGreenKey: Spotlight on Reilly Hickey

Reilly graduated from Pace University in 2018 with a degree in Arts & Entertainment Management. She worked in casting for...
Read More
Green Key Unlocked: Keys to Success in Agency Recruiting

Green Key Unlocked: Keys to Success in Agency Recruiting

Becoming a successful recruiter is no easy feat. Staffing is an industry that requires specific skills and persistence in order...
Read More
Resume Tricks for 2022

Resume Tricks for 2022

To keep you on top of the resume trends, we've put together a comprehensive list of tricks and tips to...
Read More